VenetoclaxLaboratory tumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1745卷 / 1期

关键词：

D O I：

10.1007/s40278-019-59429-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：266 / 266

相关论文

共 50 条

[1] DNA methylation inhibitors/venetoclaxLaboratory tumour lysis syndrome: case report
Reactions Weekly, 2021, 1847 (1) : 184 - 184
[2] NilotinibFirst report of tumour lysis syndrome: case report
Reactions Weekly, 2008, 1193 (1) : 21 - 21
[3] BromopyruvateFirst report of tumour lysis syndrome: case report
Reactions Weekly, 2012, 1405 (1) : 11 - 11
[4] Azacitidine/venetoclaxLaboratory and clinical tumour lysis syndrome, renal impairment and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1955 (1) : 81 - 81
[5] Case report: Acute tumour lysis syndrome
Chuah, CTH
Lim, LC
ANNALS ACADEMY OF MEDICINE SINGAPORE, 2001, 30 (01) : 55 - 57
[6] AntineoplasticsExacerbation of tumour lysis syndrome: case report
Reactions Weekly, 2021, 1876 (1) : 43 - 43
[7] ThalidomideFirst report of tumour lysis syndrome: case report
Reactions Weekly, 2002, 908 (1) : 10 - 11
[8] EribulinFirst report of tumour lysis syndrome: case report
Reactions Weekly, 2019, 1743 (1) : 86 - 86
[9] SorafenibFatal tumour lysis syndrome: case report
Reactions Weekly, 2010, 1292 (1) : 34 - 34
[10] VenetoclaxClinical tumour lysis syndrome: case report
Reactions Weekly, 2023, 1947 (1) : 408 - 408

← 1 2 3 4 5 →